SNSF
OHAMR – One Health Antimicrobial Resistance Research Call on New Treatments
Depending on the call; check OHAMR website for current deadline
Last verified:
The OHAMR Research Call on New Treatments funds research into novel antimicrobial resistance interventions through SNSF as part of the One Health Antimicrobial Resistance partnership. Swiss researchers lead transnational consortiums with partners from multiple countries to develop and test new treatment approaches. This call prioritises research that bridges human, animal, and environmental health dimensions of AMR.
Details
| Funder | SNSF |
| Consortium | Required — multi-country consortium (transnational projects) |
| Eligible countries | CH |
Eligibility & scope
Transnational call under the OHAMR European Partnership (successor to JPI AMR) on new treatments to tackle antimicrobial resistance. Swiss researchers apply via SNSF under the same requirements as SNSF Project funding. Consortium must include researchers from several countries. See national annex for Swiss-specific submission details.
Who Should Apply
- •Swiss researchers eligible to hold SNSF Project grants
- •Principal investigators prepared to convene and lead a transnational consortium
- •Research teams with expertise in antimicrobial resistance therapeutics or diagnostics
- •Groups bridging clinical, veterinary, or environmental health perspectives on AMR
Key Dates
- •Deadline varies by call round; verify on the OHAMR partnership website
- •Transnational consortium coordination required at submission
- •Project duration subject to standard SNSF Project grant terms
Tips for Applicants
- ✓Consortium strength is scored: name your international partners early and secure commitment letters before submission.
- ✓Frame your treatment innovation within the One Health paradigm, panels prioritise solutions addressing AMR across human, animal, and environmental domains.
- ✓Check the OHAMR national annex for Swiss-specific eligibility and budget rules; they supplement the core SNSF Project guidelines.
Frequently Asked Questions
Do I need to form an international consortium to apply to OHAMR?
Yes, a transnational consortium with researchers from multiple countries is required. As a Swiss applicant, you lead through SNSF.
What research areas does the OHAMR call cover?
The call focuses on new treatments to tackle antimicrobial resistance, spanning human, animal, and environmental health under the One Health framework.
Do standard SNSF Project grant rules apply?
Yes, general SNSF Project funding requirements apply, but consult the national annex for Switzerland-specific terms and budget ceilings.
Is there a fixed deadline for the OHAMR call?
Deadlines vary by call round; check the OHAMR partnership website and SNSF call details for the specific deadline for the round you plan to enter.
Related on Grantsby
- SNSF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from SNSF
SNSF Postdoc.Mobility 2026
Deadline: 4 Aug 2026Subsistence grant + travel allowance, ~24 months (+ optional 3-12mo return phase)Postdoc.Mobility
Deadline: 4 Aug 2026Subsistence grant + travel flat-rate + possible research/conference costs + return grant (salary + social security)Weave Lead Agency – South Africa
Deadline: 28 Aug 2026Weave Lead Agency – Croatia
Deadline: 1 Oct 2026Weave Lead Agency – Luxembourg
Deadline: 1 Oct 2026
Browse Related
Could OHAMR – One Health Antimicrobial Resistance Research Call on New Treatments be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →